Meanwhile.... Amplia CEO and MD Dr Chris Burns commented: “To be reporting that three confirmed partial
responses have been observed so early in this stage of the trial is extremely encouraging. We are well
on track to reach the efficacy threshold of six confirmed partial or complete responses by the end of
this quarter, which will then allow us to restart the trial to recruit the full cohort of fifty patients.”
Place your bet... All in for me
Ann: Sustained Reduction in Tumour Size Seen In Pancreatic Trial, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $116.7M | |||
| Open | High | Low | Value | Volume |
| 24.5¢ | 24.5¢ | 23.5¢ | $951.7K | 3.939M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 19377 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 152052 | 4 |
View Market Depth
| Last trade - 16.10pm 31/07/2025 (20 minute delay) ? |
| ATX (ASX) Chart |